Histology
Non-Small Cell Carcinoma
CI-CAN-00001292Explore in graph →
1,752 active trials47 approved drugs589 evidence items
- NCIt
- C65151
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00001292Explore in graph →
Clinical trials
6,757 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,046)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00115518 | Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 30 | Heidelberg UniversityOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT00040638 | Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 40 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00047801 |
| Phase 1-2a Dose-Ranging Study of TLK286 in Combination With Docetaxel in Platinum-Resistant Non-Small Cell Lung Cancer |
| completed |
| Phase 1 / Phase 2 |
| 28 |
| TelikINDUSTRY |
| 1 |
| Jul 25, 2011 |
| clinicaltrials |
| NCT00077883 | TLK286 (Telcyta) in Combination With Cisplatin for Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 50 | TelikINDUSTRY | 1 | Jul 25, 2011 | clinicaltrials |
| NCT00708812 | Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 126 | Shandong Simcere-Medgenn Bio-pharmaceutical Co., LtdINDUSTRY | 1 | Jul 21, 2011 | clinicaltrials |
| NCT01282450 | Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 60 | Maastricht Radiation OncologyOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00293085 | An Open, Randomized, Multicentre, Phase II Pilot Study | completed | Phase 2 | 37 | Central European Cooperative Oncology GroupOTHER | 0 | Jun 23, 2011 | clinicaltrials |
| NCT00531401 | Study of Salirasib to Treat Non-Small Cell Lung Cancer | completed | Phase 2 | 71 | Concordia Pharmaceuticals, IncINDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
| NCT00343291 | A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC | completed | Phase 2 | 121 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 7, 2011 | clinicaltrials |
| NCT00614965 | Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV | completed | Phase 2 | 124 | Hellenic Oncology Research GroupOTHER | 1 | May 23, 2011 | clinicaltrials |
| NCT01024062 | Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 60 | Bristol-Myers SquibbINDUSTRY | 0 | Apr 25, 2011 | clinicaltrials |
| NCT00687817 | Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 49 | Peregrine PharmaceuticalsINDUSTRY | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00372775 | Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases | completed | Phase 2 | 66 | PfizerINDUSTRY | 4 | Feb 24, 2011 | clinicaltrials |
| NCT00819728 | Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 35 | SanofiINDUSTRY | 1 | Jan 11, 2011 | clinicaltrials |
| NCT00609518 | A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer | completed | Phase 2 | 111 | Eli Lilly and CompanyINDUSTRY | 4 | Dec 28, 2010 | clinicaltrials |
| NCT00321815 | Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer | completed | Phase 2 | 43 | PfizerINDUSTRY | 1 | Dec 23, 2010 | clinicaltrials |
| NCT00061451 | Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Clinical Trial | completed | Phase 2 | 48 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 22, 2010 | clinicaltrials |
| NCT00192036 | Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer | completed | Phase 2 | 49 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 9, 2010 | clinicaltrials |
| NCT00434668 | Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer(TOLEDO) | completed | Phase 2 | 99 | University Hospital, AntwerpOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00101920 | ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | 50 | AmgenINDUSTRY | 0 | Oct 15, 2010 | clinicaltrials |
| NCT00350792 | Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients | completed | Phase 2 | 62 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00085813 | Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | GlaxoSmithKlineINDUSTRY | 3 | Oct 4, 2010 | clinicaltrials |
| NCT00315185 | Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer | completed | Phase 2 | 53 | Fox Chase Cancer CenterOTHER | 1 | Sep 23, 2010 | clinicaltrials |
| NCT00409006 | Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 3 | Sep 9, 2010 | clinicaltrials |
| NCT00312819 | Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer | completed | Phase 2 / Phase 3 | 60 | Hadassah Medical OrganizationOTHER | 1 | Aug 31, 2010 | clinicaltrials |
| NCT00544960 | A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer | completed | Phase 2 | 106 | Ascenta TherapeuticsINDUSTRY | 3 | Aug 27, 2010 | clinicaltrials |
| NCT00316225 | Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen | completed | Phase 2 | 31 | Eli Lilly and CompanyINDUSTRY | 3 | Jul 9, 2010 | clinicaltrials |
| NCT00113516 | A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 84 | PfizerINDUSTRY | 3 | May 18, 2010 | clinicaltrials |
| NCT00318136 | A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) | completed | Phase 2 | 47 | Genentech, Inc.INDUSTRY | 0 | May 11, 2010 | clinicaltrials |
| NCT00198393 | Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV | completed | Phase 2 | 126 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Apr 30, 2010 | clinicaltrials |
| NCT00063388 | Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer | completed | Phase 2 | 66 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 12, 2010 | clinicaltrials |
| NCT00034541 | Study of Cetuximab in Combination With Carboplatin-Paclitaxel in Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 32 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00097214 | Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 57 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00097227 | Trial of Carboplatin/Paclitaxel/Cetuximab in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 165 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 9, 2010 | clinicaltrials |
| NCT00103831 | Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 2 | Mar 2, 2010 | clinicaltrials |
| NCT00191139 | Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 64 | Eli Lilly and CompanyINDUSTRY | 4 | Feb 17, 2010 | clinicaltrials |
| NCT00402051 | Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 133 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 17, 2010 | clinicaltrials |
| NCT00128999 | Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 5 | Alberta Health servicesOTHER | 1 | Feb 9, 2010 | clinicaltrials |
| NCT01048645 | Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 107 | National Institute of CancerologíaOTHER_GOV | 1 | Jan 13, 2010 | clinicaltrials |
| NCT01037998 | UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer | completed | Phase 2 | 115 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Dec 23, 2009 | clinicaltrials |
| NCT00615758 | Erlotinib as 1st Line Treatment in NSCLC Stage IIIB/IV | completed | Phase 2 | 50 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00684099 | Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 70 | Hellenic Oncology Research GroupOTHER | 1 | Dec 15, 2009 | clinicaltrials |
| NCT00191191 | To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 226 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00271271 | Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients(GON) | completed | Phase 2 | 40 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00424853 | ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC) | completed | Phase 2 | 88 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00425191 | Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer. | completed | Phase 2 | 165 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00370292 | Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 19 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 20, 2009 | clinicaltrials |
| NCT00212043 | Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell Carcinoma | completed | Phase 2 | 74 | National University Hospital, SingaporeOTHER | 0 | Oct 8, 2009 | clinicaltrials |
| NCT00063219 | Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy | completed | Phase 2 | 48 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Aug 21, 2009 | clinicaltrials |
| NCT00067548 | Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 44 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Aug 21, 2009 | clinicaltrials |
Data updated 23 days agoSource updated Aug 5, 2011source: clinicaltrials